re: Ann: BNC105 Achieves High Response Rate i... This is a non-event in spite of the PR headlines. 15 patients do not prove anything. It seems to have better outcome than mesathelioma trial.
The trial of renal cell carcinoma is the main event for Bionomics. I thought that those results would be out by now. Well.. they WILL be out by end of March. Keeping fingers crossed!
- Forums
- ASX - By Stock
- BNO
- Ann: BNC105 Achieves High Response Rate in Ovaria
Ann: BNC105 Achieves High Response Rate in Ovaria, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online